Read + Share
Fujimoto N, Minato A, Igawa T, Hiroshige T, et al. Immediate Prostate-specific Antigen Decline After Enzalutamide Following
Abiraterone Predicts Survival in Castration-resistant Disease. Anticancer Res 2022;42:3041-3047.
PMID: 35641266
|
 |
|
Fujimoto N, Minato A, Igawa T, Hiroshige T, et al. Immediate Prostate-specific Antigen Decline After Enzalutamide Following
Abiraterone Predicts Survival in Castration-resistant Disease. Anticancer Res 2022;42:3041-3047.
PMID: 35641266
|
|
|
|